MYCN and neuroblastoma: Moreover, as our previous study showed, inhibition of the glycolytic pathway through oncogenic silencing of MYCN reduces glycolytic parameters, but in turn, the FAO pathway becomes dominant for energy reprogramming in the neuroblastoma cell lines.